Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1995 1
1998 4
1999 2
2000 2
2001 2
2002 4
2003 3
2004 4
2005 1
2006 3
2007 2
2008 2
2009 3
2010 5
2011 2
2012 3
2014 1
2016 4
2017 3
2019 1
2020 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Educating pharmacy students through a pandemic: Reflecting on our COVID-19 experience.
Strawbridge J, Hayden JC, Robson T, Flood M, Cullinan S, Lynch M, Morgan AT, O'Brien F, Reynolds R, Kerrigan SW, Cavalleri G, Kirby BP, Tighe O, Maher A, Barlow JW. Strawbridge J, et al. Among authors: tighe o. Res Social Adm Pharm. 2022 Jul;18(7):3204-3209. doi: 10.1016/j.sapharm.2021.08.007. Epub 2021 Aug 17. Res Social Adm Pharm. 2022. PMID: 34483082 Free PMC article.
Schizophrenia-related endophenotypes in heterozygous neuregulin-1 'knockout' mice.
O'Tuathaigh CM, Harte M, O'Leary C, O'Sullivan GJ, Blau C, Lai D, Harvey RP, Tighe O, Fagan AJ, Kerskens C, Reynolds GP, Waddington JL. O'Tuathaigh CM, et al. Among authors: tighe o. Eur J Neurosci. 2010 Jan;31(2):349-58. doi: 10.1111/j.1460-9568.2009.07069.x. Epub 2010 Jan 13. Eur J Neurosci. 2010. PMID: 20074216
Ethologically based behavioural and neurochemical characterisation of mice with isoform-specific loss of dysbindin-1A in the context of schizophrenia.
O'Tuathaigh CMP, Desbonnet L, Payne C, Petit E 1st, Cox R, Loftus S, Clarke G, Cryan JF, Tighe O, Wilson S, Kirby BP, Dinan TG, Waddington JL. O'Tuathaigh CMP, et al. Among authors: tighe o. Neurosci Lett. 2020 Sep 25;736:135218. doi: 10.1016/j.neulet.2020.135218. Epub 2020 Jun 29. Neurosci Lett. 2020. PMID: 32615248 Free article.
Epistatic and Independent Effects on Schizophrenia-Related Phenotypes Following Co-disruption of the Risk Factors Neuregulin-1 × DISC1.
O'Tuathaigh CM, Fumagalli F, Desbonnet L, Perez-Branguli F, Moloney G, Loftus S, O'Leary C, Petit E, Cox R, Tighe O, Clarke G, Lai D, Harvey RP, Cryan JF, Mitchell KJ, Dinan TG, Riva MA, Waddington JL. O'Tuathaigh CM, et al. Among authors: tighe o. Schizophr Bull. 2017 Jan;43(1):214-225. doi: 10.1093/schbul/sbw120. Epub 2016 Sep 9. Schizophr Bull. 2017. PMID: 27613806 Free PMC article.
Dysregulation of Specialized Delay/Interference-Dependent Working Memory Following Loss of Dysbindin-1A in Schizophrenia-Related Phenotypes.
Petit EI, Michalak Z, Cox R, O'Tuathaigh CM, Clarke N, Tighe O, Talbot K, Blake D, Joel J, Shaw A, Sheardown SA, Morrison AD, Wilson S, Shapland EM, Henshall DC, Kew JN, Kirby BP, Waddington JL. Petit EI, et al. Among authors: tighe o. Neuropsychopharmacology. 2017 May;42(6):1349-1360. doi: 10.1038/npp.2016.282. Epub 2016 Dec 16. Neuropsychopharmacology. 2017. PMID: 27986973 Free PMC article.
Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes.
O'Tuathaigh CM, Clarke G, Walsh J, Desbonnet L, Petit E, O'Leary C, Tighe O, Clarke N, Karayiorgou M, Gogos JA, Dinan TG, Cryan JF, Waddington JL. O'Tuathaigh CM, et al. Among authors: tighe o. Int J Neuropsychopharmacol. 2012 Oct;15(9):1331-42. doi: 10.1017/S1461145711001581. Epub 2011 Nov 11. Int J Neuropsychopharmacol. 2012. PMID: 22074909 Free article.
48 results